University of Groningenfounded in 1614  -  top 100 university
Close
How to find us prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma
Telephone:
+31 50 361 5084 (secretary)
E-mail:
m.j.postma rug.nl

Research

Research units:

1 - 41 out of 41Page size: 50
  1. van Aalst, R. (2020). An economic assessment of high-dose influenza vaccine: Estimating the vaccine-preventable burden of disease in the United States using real-world data. University of Groningen. https://doi.org/10.33612/diss.127973664
  2. Jacobs, M. (2020). Anticoagulation in Atrial Fibrillation: Consideration for treatment and health economic aspects. University of Groningen. https://doi.org/10.33612/diss.132895541
  3. Boer ,de, P. T. (2020). Cost-effectiveness of vaccination strategies to protect older adults: Focus on herpes zoster and influenza. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.126806948
  4. de Jong, L. (2020). Health economics of direct oral anticoagulants in the Netherlands. University of Groningen. https://doi.org/10.33612/diss.129441687
  5. Wasir, R. (2020). Moving forward to achieve universal health coverage in Indonesia. University of Groningen. https://doi.org/10.33612/diss.124431881
  6. Purba, A. (2020). Pharmacoeconomics of prophylactic, empirical, and diagnostic-based antibiotic treatments: Focus on surgical site infection and hospitalized community-acquired pneumonia. University of Groningen. https://doi.org/10.33612/diss.128518764
  7. Larmené-Beld, K. (2020). Ready to administer parenteral medication produced by the hospital pharmacy: cost, labeling and quality. University of Groningen. https://doi.org/10.33612/diss.144367021
  8. Ong, K. J. (2019). Economic aspects of public health programmes for infectious disease control: studies on human immunodeficiency virus & human papillomavirus. University of Groningen. https://doi.org/10.33612/diss.98545253
  9. Huang, Y. (2019). Use of real-world evidence in pharmacoeconomic analysis: illustrations in The Netherlands and China. University of Groningen. https://doi.org/10.33612/diss.95669767
  10. Arifin, B. (2018). Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients. University of Groningen.
  11. van Wijhe, M. (2018). The public health impact of vaccination programmes in the Netherlands: A historical analysis of mortality, morbidity, and costs. University of Groningen.
  12. Zakiyah, N. (2018). Women's health from a global economic perspective. University of Groningen.
  13. Setiawan, D. (2017). HPV vaccination in Indonesia: A health-economic & comparative perspective. University of Groningen.
  14. Fugel, H-J. (2016). Economics of stratified medicine: Challenges and opportunities in adapting stratified medicine approaches to enhance patient access, population health, cost-effectiveness and return on investment. University of Groningen.
  15. Mafirakureva, N. (2016). Health economics of blood transfusion in Zimbabwe. University of Groningen.
  16. Nguyen, T. P. L. (2016). Health economics of screening for hypertension in Vietnam. University of Groningen.
  17. Mihajlovic, J. (2016). Health economics of targeted cancer therapies: A comparative analysis for Serbia and the Netherlands. Rijksuniversiteit Groningen.
  18. Smit, R. (2016). Health economics of tick-borne diseases. Rijksuniversiteit Groningen.
  19. Dik, J-W. (2016). Impact of medical microbiology: A clinical and financial analysis. Rijksuniversiteit Groningen.
  20. Mapako, T. (2016). Risk modelling of transfusion transmissible infections. University of Groningen.
  21. de Vries, F. M. (2016). Statin treatment in type 2 diabetes patients. Rijksuniversiteit Groningen.
  22. Heeg, B. M. S. (2015). Developing health economic models of chronic diseases for reimbursement purposes. University of Groningen. https://doi.org/10.1016/j.jval.2014.12.008
  23. van Boven, J. F. M. (2015). Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness. University of Groningen.
  24. Standaert, B. A. C. G. M. (2015). Exploring new ways of measuring the economic value of vaccination with an application to the prevention of rotaviral disease. University of Groningen.
  25. Kotsopoulos, N. (2015). Novel economic perspectives on prevention and treatment : case studies for paediatric, adolescent and adult infectious and chronic diseases. University of Groningen.
  26. Stevanovic, J. (2015). Pharmacoeconomics of cardiovascular disease prevention. University of Groningen.
  27. Pitman, J. P. (2015). The influence and impact of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) on blood transfusion services in Africa: Case studies from Namibia. University of Groningen.
  28. Suwantika, A. A. (2014). Economic evaluations of non-traditional vaccinations in middle-income countries: Indonesia as a reference case. s.n.
  29. Rozenbaum, M. H. (2013). Costs and effectiveness of extended vaccination strategies against pertussis and pneumococcal disease.
  30. Westra, T. A. (2013). Health-economic modelling of human Papillomavirus vaccination. [S.n.].
  31. van Hasselt, F. M. (2013). Improving the physical health of people with severe mental illness: the need for tailor made care and uniform evaluation of interventions. s.n.
  32. Parouty, M. B. Y. (2013). Inequality aversion to posterity: discounting human lives. s.n.
  33. van Hoek, A. J. (2013). The epidemiology and cost-effectiveness of vaccination strategies against infectious diseases: a focus on Varicella zoster, pandemic influenza A/H1N1 2009, and Streptococcus pneumoniae. [S.n.].
  34. Tu, H. A. T. (2012). Health economics of new and under-used vaccines in developing countries: state-of-the-art analyses for hepatitis B and rotavirus in Vietnam. s.n.
  35. Vegter, S. (2012). The value of personalized approaches to improve pharmacotherapy in renal disease. s.n.
  36. Krabbe Lugnér, A. K. (2011). Cost-effectiveness of controlling infectious diseases from a public health perspective. [s.n.].
  37. Connolly, M. P. (2010). The Economics of assisted reproduction: costs and consequences of fertility treatments. [s.n.].
  38. Hubben, G. A. A. (2009). Cost-effectiveness of infectious disease interventions: combining economic modelling and web technology to support decision making. [s.n.].
  39. Boersma, C. (2009). Health economics of cardiovascular & renal disease prevention: from clinical trials to real-life settings. s.n.
  40. de Vries, R. (2009). Health-economics of interventions aimed at infectious diseases: dynamic modeling inevitable for reliable decision making. s.n.
  41. Hulst, M. V. (2008). Health economics of blood transfusion safety. s.n.

ID: 193217

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube